AMBALAL SARABHAI ENTERPRISES
Back to Balance Sheet
|
AMBALAL SARABHAI ENTERPRISES Last 5 Year Total Non-Current Liabilities History
[Consolidated]
| Mar2025 | Mar2024 | Mar2023 | Mar2022 | Mar2021 | |
|---|---|---|---|---|---|
| Total Non-Current Liabilities | ₹7.85 Cr | ₹11 Cr | ₹12 Cr | ₹4.73 Cr | ₹5.35 Cr |
What is the latest Total Non-Current Liabilities ratio of AMBALAL SARABHAI ENTERPRISES ?
| Year | Total Non-Current Liabilities |
|---|---|
| Mar2025 | ₹7.85 Cr |
| Mar2024 | ₹11 Cr |
| Mar2023 | ₹12 Cr |
| Mar2022 | ₹4.73 Cr |
| Mar2021 | ₹5.35 Cr |
How is Total Non-Current Liabilities of AMBALAL SARABHAI ENTERPRISES Trending?
| Years | Total Non-Current Liabilities | % Change | |
|---|---|---|---|
| Mar2025 | ₹7.85 Cr | -27.18 | |
| Mar2024 | ₹11 Cr | -9.70 | |
| Mar2023 | ₹12 Cr | 152.61 | |
| Mar2022 | ₹4.73 Cr | -11.63 | |
| Mar2021 | ₹5.35 Cr | - | |
Compare Total Non-Current Liabilities of peers of AMBALAL SARABHAI ENTERPRISES
| Peers & Returns | Market Capitalization | 1 Week | 1 Month | 1 Year | ||
| AMBALAL SARABHAI ENTERPRISES | ₹218.9 Cr | -8% | 0.2% | -50.2% | Stock Analytics | |
| SUN PHARMACEUTICAL INDUSTRIES | ₹412,626.0 Cr | -1% | -4.9% | -7.6% | Stock Analytics | |
| DIVIS LABORATORIES | ₹169,758.0 Cr | -1.6% | -0.4% | 9.4% | Stock Analytics | |
| TORRENT PHARMACEUTICALS | ₹130,021.0 Cr | 0.2% | 2.8% | 12.2% | Stock Analytics | |
| CIPLA | ₹122,046.0 Cr | 1% | -0.9% | -1% | Stock Analytics | |
| DR REDDYS LABORATORIES | ₹106,086.0 Cr | 0.4% | 0.9% | -8.9% | Stock Analytics | |
AMBALAL SARABHAI ENTERPRISES Share Price vs Sensex
| Share Price Returns(%) | 1 Week | 1 Month | 1 Year |
| AMBALAL SARABHAI ENTERPRISES | -8% |
0.2% |
-50.2% |
| SENSEX | -0.4% |
-0.6% |
8.6% |
You may also like the below Video Courses